MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's Disease

Jonathan R Dillman1, Jean A Tkach1, Joel G Fletcher2

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

PubMed

Insights

Normalized 3D MTR and GM-CSF autoantibodies are linked to surgical needs in ileal Crohn's disease. These biomarkers may help predict which patients require surgery, improving treatment strategies for this condition.

Area of Science:

  • Gastroenterology
  • Radiology
  • Immunology

Background:

  • Ileal Crohn's disease (CD) often progresses to fibrostenosis, necessitating surgery despite medical advancements.
  • Identifying predictive biomarkers for surgical intervention in CD is crucial for patient management.

Purpose of the Study:

  • To identify magnetic resonance imaging (MRI) and circulating biomarkers associated with the need for surgical management in pediatric and adult patients with ileal CD.

Main Methods:

  • A prospective, multicenter study involving pediatric and adult CD patients undergoing ileal resection or medical therapy.
  • MRI techniques included normalized 3D MTR, MOLLI T1, IVIM, and sMaRIA.
  • Circulating biomarkers measured were CD64, ECM1, and GM-CSF autoantibodies (Ab).
  • LASSO regression was used to analyze associations between biomarkers and the need for ileal resection.

Main Results:

  • Univariate analysis showed associations between ileal resection and log GM-CSF Ab, normalized 3D MTR, log MOLLI T1, log IVIM perfusion fraction (f), and IVIM ADC.
  • Multivariable analysis identified log GM-CSF Ab, normalized 3D MTR, and luminal narrowing as significant predictors for surgery.
  • Normalized 3D MTR and GM-CSF Ab remained associated with surgical need after adjusting for clinical and MRI severity measures.

Conclusions:

  • Normalized 3D MTR and GM-CSF Ab are independently associated with the need for surgery in patients with ileal CD.
  • These biomarkers show potential for predicting surgical outcomes in ileal CD patients.
  • Further research can explore integrating these biomarkers into clinical decision-making for CD management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
145
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
219
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
166
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131